The humanized NOD/SCID mouse as a preclinical model to study the fate of encapsulated human islets.

The review of diabetic studies : RDS

Volumn 7, Issue 1, 2010, Pages 62-73

  Vaithilingam, Vijayaganapathy ^a   Oberholzer, Jose ^b   Guillemin, Gilles J ^b   Tuch, Bernard E ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BIOMATERIAL; CHEMOKINE; CYTOKINE; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL; ARTICLE; ASCITES FLUID; CHEMISTRY; DISEASE MODEL; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET TRANSPLANTATION; SCID MOUSE; T LYMPHOCYTE; TRANSPLANTATION; XENOGRAFT;

ALGINATES; ANIMALS; ASCITIC FLUID; BIOCOMPATIBLE MATERIALS; BLOOD GLUCOSE; CHEMOKINES; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; GLUCURONIC ACID; GRAFT REJECTION; HEXURONIC ACIDS; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84891700357     PISSN: None     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2010.7.62     Document Type: Article

References (0)